NIH-funded research R01 grant

Investigating how specific lipids affect heart and immune cell function in children with a rare heart condition.

Official title: Glycosphingolipid-Mediated Cardiomyocyte and Immune Cell Dysfunction in Hypoplastic Left Heart Syndrome

Funded at University of Colorado Denver · NIH-11086778 · Data updated 2026-11-12

This study is looking at how certain fats in the body might affect heart health in people with Hypoplastic Left Heart Syndrome (HLHS), with the goal of finding new ways to help improve their heart function.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startJune 1, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$511,829
NIH project number5R01HL171600-02
Project IDNIH-11086778 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include children and adults diagnosed with Hypoplastic Left Heart Syndrome who are experiencing heart dysfunction.

Less likely to help

Patients with other types of congenital heart defects or those without heart-related issues may not benefit from this research.

What this research studies

This research focuses on understanding the mechanisms that lead to heart failure in patients with Hypoplastic Left Heart Syndrome (HLHS), a condition where the left side of the heart is underdeveloped. The study examines the role of glycosphingolipids, particularly LacCer, in affecting heart muscle cells and immune responses. By analyzing how these lipids influence cellular functions, the research aims to identify potential therapeutic targets that could improve heart health in HLHS patients. The approach includes both laboratory experiments with heart cells and studies involving patient samples to gather comprehensive data.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve heart function and overall health for children and adults with Hypoplastic Left Heart Syndrome.

How similar studies have gone: While the specific focus on glycosphingolipids in HLHS is novel, similar research has shown that understanding lipid metabolism can lead to breakthroughs in heart disease treatment.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Garcia, Anastacia M — University of Colorado Denver
  • Study coordinator: Garcia, Anastacia M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.